Greenyn Biotechnology Co (ROCO:6846) Total Equity: NT$978.6 Mil (As of Dec. 2025)


ROCO:6846 Greenyn Biotechnology Co Ltd ROCO:6846
64 GF Score
Price NT$66.90
GF Value NT$66.78
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Greenyn Biotechnology Co Total Equity?

Greenyn Biotechnology Co ROCO:6846 64 Total Equity is NT$978.6 Mil as of Dec. 2025. GuruFocus rates ROCO:6846 with a GF Score™ of 64/100 and a GF Value™ of NT$66.78 (Fairly Valued). The stock has 7 warning signs investors should review.

Greenyn Biotechnology Co's total equity for the quarter that ended in Dec. 2025 was NT$978.6 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Greenyn Biotechnology Co Total Equity Historical Data

* Premium members only.

The historical data trend for Greenyn Biotechnology Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenyn Biotechnology Co Total Equity Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 613.77 562.02 796.91 851.35 978.56

Greenyn Biotechnology Co Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 851.35 876.14 896.31 926.50 978.56
ROCO:6846
64GF Score
Greenyn Biotechnology Co Ltd ROCO:6846
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenyn Biotechnology Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Greenyn Biotechnology Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2109.409-1130.85
=978.6

Greenyn Biotechnology Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2109.409-1130.85
=978.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$978.6 Mil mean?
Greenyn Biotechnology Co (ROCO:6846) has a Total Equity of NT$978.6 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Greenyn Biotechnology Co and its competitors.
Is Greenyn Biotechnology Co's Total Equity too high?
Greenyn Biotechnology Co's current Total Equity is NT$978.6 Mil. Overall, Greenyn Biotechnology Co has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Greenyn Biotechnology Co's Total Equity compare to VRTX and REGN?
Greenyn Biotechnology Co's Total Equity of NT$978.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Greenyn Biotechnology Co and its competitors. Greenyn Biotechnology Co's current Total Equity is NT$978.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenyn Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Greenyn Biotechnology Co (ROCO:6846) is currently considered Fairly Valued. The stock's GF Value™ is NT$66.78, compared to a current price of NT$66.90 — trading 0.2% above its estimated fair value. The current Total Equity is NT$978.6 Mil. Greenyn Biotechnology Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Greenyn Biotechnology Co (ROCO:6846), the current Total Equity is NT$978.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Greenyn Biotechnology Co (ROCO:6846) Overvalued in 2026?

Based on GuruFocus' analysis, Greenyn Biotechnology Co stock appears to be overvalued. The current stock price of NT$66.90 is trading 0.2% above its estimated GF Value™ of NT$66.78. GuruFocus considers Greenyn Biotechnology Co to be Fairly Valued.

Key valuation signals for ROCO:6846:

  • Total Equity: NT$978.6 Mil
  • GF Value™: NT$66.78 vs. price of NT$66.90 (0.2% above fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Greenyn Biotechnology Co Business Description

Address No 43 Keya Road, 5th Floor, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd is engaged in the business of health food raw materials production and sales of raw materials and production and sales of formula preparation.
64GF Score

Get the complete analysis for ROCO:6846

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$66.90
Price
NT$66.78
GF Value